Trials / Conditions / Adenocarcinoma of the Extrahepatic Bile Duct
Adenocarcinoma of the Extrahepatic Bile Duct
3 registered clinical trials studyying Adenocarcinoma of the Extrahepatic Bile Duct.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer Th NCT00478140 | National Cancer Institute (NCI) | Phase 2 |
| Completed | S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma NCT00238212 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Du NCT00085410 | National Cancer Institute (NCI) | Phase 2 |